June 14, 2018 6:14pm
As NASDAQ hits another all-time high
Perception and pricing are contradictory with regard to risk
Pre-open indications: 1 HIT and 3 MISS
Out and about: Verastem Oncology (VSTM) announced a registered sale to funds managed by Consonance Capital of 7,166,666 shares priced at $6.00 per share for gross proceeds of $43 million. VSTM closed down -$0.08 and is up +$0.36 or +6.45% in the aftermarket
Of the 45 covered, the 18 downside equities finished in a range of -$0.01 to -$0.70 with biggest bottoms of -$4.68, $3.00 and $1.00 while the 26 upside equities oscillated from +$0.01 to $2.06 with a topper of $8.90, $4.20 and $3.47 with 1 flat closes
We keep you informed, if you want to make a return on investment (ROI) from the sector - be a subscriber!
There is no breadline for fact based intelligence!
Members only. Please login.